Loading…
5 companies · GEL, thousands · columns ordered by revenue
GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series
| Metric | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,002 | 7,023 | 22,244 | 12,894 | 9,133 | 9,435 | 6,042 | 2,800 |
| EBITDA | 1,150 | 619 | 2,175 | 34 | -299 | -722 | 39 | 170 |
| Net profit | -580 | 8,872 | 2,033 | -290 | -1,402 | -334 | -87 | 4 |
| Total assets | 18,566 | 30,498 | 21,393 | 22,495 | 21,095 | 4,599 | 6,220 | 5,352 |
| n (companies reporting) | 3 | 4 | 3 | 3 | 4 | 3 | 3 | 2 |
GEL, thousands
| Company | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|---|
| Elelgrupi | — | — | — | — | 0 | 2,189 | 1,699 | 1,524 |
| Pip Company | 0 | 1,452 | 1,575 | 1,810 | 2,112 | 2,309 | 3,003 | 1,276 |
| Grasse Pharma Georgia | — | 0 | 15,908 | 5,721 | 1,400 | — | — | — |
| Sando Pharma | 0 | 4,272 | 4,761 | 5,363 | 5,621 | 4,936 | 1,341 | — |
| Medimex | 2,002 | 1,299 | — | — | — | — | — | — |
Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.
Peer coverage varies by year — FY2017–FY2024 pool fewer than the 5 picked companies (see the n row). A year is never dropped because one peer is missing.
Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.